Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Dec 12, 2024 3:23pm

211 Views

Post# 36359658

Crazy world of health care valuations

Saw an article on my feed re Keros (KROS). Working on pulm art hypertension drug. This is not a common condition. Rest of pipeline is wishful.

WAS market capped at 2.8 B

Just reported some not great clinical info on their drug and value drops 73% today. They lost almost 2B USD valuation in one day.

Put another way, they lost value that was equivalent to 40 x TLT. Now only valued at 19 x TLT.

I really believe much of valuation is based on PR and Perception and Hype. If you add in a real drug and a real set of possibilities (multiple cancer types) and we get the PR train going, at some point....that would be amazing.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide